Caveolin‐1 mediates tissue plasminogen activator‐induced MMP‐9 up‐regulation in cultured brain microvascular endothelial cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neurochemistry

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/jnc.13065PMID 25683686
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue plasminogen activator (tPA) treatment for COVID 19 associated respiratory failure: A case Series

  2022influential reference
• Knock down of caveolin‐1 affects morphological and functional hallmarks of human endothelial cells

  2013influential reference
• Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood–Brain Barrier Damage in Early Ischemic Stroke Stage

  2012cited by this paper
• Caveolin‐1 regulates nitric oxide‐mediated matrix metalloproteinases activity and blood–brain barrier permeability in focal cerebral ischemia and reperfusion injury

  2012influential reference
• PPARα and PPARγ protect against HIV‐1‐induced MMP‐9 overexpression via caveolae‐associated ERK and Akt signaling

  2011cited by this paper
• Quantitative Temporal Profiles of Penumbra and Infarction During Permanent Middle Cerebral Artery Occlusion in Rats

  2010cited by this paper
• Normobaric Hyperoxia Reduces the Neurovascular Complications Associated With Delayed Tissue Plasminogen Activator Treatment in a Rat Model of Focal Cerebral Ischemia

  2009cited by this paper
• The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production.

  2009cited by this paper
• Multiphasic roles for matrix metalloproteinases after stroke.

  2008cited by this paper
• Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood–brain barrier breakdown

  2007cited by this paper
• Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart.

  2007cited by this paper
• Caveolin-1 Deficiency Increases Cerebral Ischemic Injury

  2007cited by this paper
• Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications.

  2007cited by this paper
• Differential expression of tissue inhibitor of metalloproteinases‐3 in cultured astrocytes and neurons regulates the activation of matrix metalloproteinase‐2

  2007cited by this paper
• Caveolin-1 Regulates the Delivery and Endocytosis of the Glutamate Transporter, Excitatory Amino Acid Carrier 1*

  2007cited by this paper
• Nitric oxide down‐regulates caveolin‐1 expression in rat brains during focal cerebral ischemia and reperfusion injury

  2006cited by this paper
• Reduction of Tissue Plasminogen Activator-Induced Matrix Metalloproteinase-9 by Simvastatin in Astrocytes

  2006cited by this paper
• Activated protein C inhibits tissue plasminogen activator–induced brain hemorrhage

  2006cited by this paper
• Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia

  2005cited by this paper
• Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo

  2004cited by this paper
• Matrix metalloproteinases in neuroinflammation and cerebral ischemia.

  2004cited by this paper
• Plasma Cellular-Fibronectin Concentration Predicts Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic Stroke

  2004cited by this paper
• The Caveolin genes: from cell biology to medicine

  2004cited by this paper
• Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion

  2003cited by this paper
• Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator

  2003influential reference
• Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

  2003cited by this paper
• Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

  2003cited by this paper
• Essential role for ERK mitogen‐activated protein kinase in matrix metalloproteinase‐9 regulation in rat cortical astrocytes

  2003cited by this paper
• Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke

  2003cited by this paper
• Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

  2000cited by this paper
• Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase.

  2000cited by this paper
• Caveolins, Liquid-Ordered Domains, and Signal Transduction

  1999cited by this paper
• tPA in acute ischemic stroke

  1998cited by this paper
• Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke

  1998cited by this paper
• Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signaling Complexes” at the Plasma Membrane*

  1998cited by this paper
• Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion

  1996cited by this paper
• Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis.

  1994cited by this paper

• GYT-088 Restores Endothelial Function and Prevents Retinal Vascular Pathology in Non-proliferative and Proliferative Diabetic Retinopathies.

  2026cites this paper
• The Caveolin-1/NF-κB signalling pathway is involved in Kawasaki disease vasculitis induced by Lactobacillus casei cell wall extract.

  2025cites this paper
• Caveolin-1-mediated LDL transcytosis across endothelial cells in atherosclerosis.

  2025cites this paper
• Disintegration of Cav-1/β-catenin complex attenuates neuronal death after ischemia–reperfusion injury by promoting β-catenin nuclear translocation

  2024cites this paper
• Extracellular Vesicles Maintain Blood-Brain Barrier Integrity by the Suppression of Caveolin-1/CD147/VEGFR2/MMP Pathway After Ischemic Stroke

  2024cites this paper
• Exploration of the Molecular Mechanism by Which Caveolin-1 Regulates Changes in Blood–Brain Barrier Permeability Leading to Eosinophilic Meningoencephalitis

  2024cites this paper
• Synergistic effects of neuroprotective drugs with intravenous recombinant tissue plasminogen activator in acute ischemic stroke: A Bayesian network meta-analysis

  2024cites this paper
• α7nACh receptor, a promising target to reduce BBB damage by regulating inflammation and autophagy after ischemic stroke.

  2024cites this paper
• Neurovascular Inflammation and Complications of Thrombolysis Therapy in Stroke

  2023cites this paper
• Inhibiting Caveolin-1-Related Akt/mTOR Signaling Pathway Protects Against N-methyl-D-Aspartate Receptor Activation-Mediated Dysfunction of Blood–Brain Barrier in vitro

  2023cites this paper
• Human-Induced Pluripotent Stem Cell-Based Model of the Blood-Brain at 10 Years: A Retrospective on Past and Current Disease Models.

  2023cites this paper
• Hyperglycemia Aggravates Blood–Brain Barrier Disruption Following Diffuse Axonal Injury by Increasing the Levels of Inflammatory Mediators through the PPARγ/Caveolin-1/TLR4 Pathway

  2022cites this paper
• Endothelial Cells and the Cerebral Circulation.

  2022cites this paper
• Neural Stem Cells for Early Ischemic Stroke

  2021cites this paper
• Modulation of gene expression on a transcriptome-wide level following human neural stem cell transplantation in aged mouse stroke brains.

  2021cites this paper
• Role of caveolin-1 in human organ function and disease: friend or foe?

  2021cites this paper
• Oxymatrine improves blood-brain barrier integrity after cerebral ischemia-reperfusion injury by downregulating CAV1 and MMP9 expression.

  2021cites this paper
• Oxymatrine Improves the Integrity of the Blood-Brain Barrier after Cerebral Ischemia-Reperfusion Injury through the Caveolin-1/MMP-9 Signaling Pathway

  2020cites this paper
• Evaluation of long-term rt-PA effects on bEnd.3 endothelial cells under ischemic conditions; changes in ZO-1 expression and glycosylation of the bradykinin B2 receptor.

  2020cites this paper
• Amorphous silica nanoparticle-induced pulmonary inflammatory response depends on particle size and is sex-specific in rats.

  2020cites this paper
• Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains.

  2020cites this paper
• Acute Nicotine Treatment Alleviates LPS-Induced Impairment of Fear Memory Reconsolidation Through AMPK Activation and CRTC1 Upregulation in Hippocampus

  2020cites this paper
• Association between caveolin-1 and stroke: a systematic review and meta-analysis.

  2020cites this paper
• Astrocyte-derived fatty acid-binding protein 7 protects blood-brain barrier integrity through a caveolin-1/MMP signaling pathway following traumatic brain injury.

  2019cites this paper
• Matrix metalloproteinase-9 regulates the blood brain barrier via the hedgehog pathway in a rat model of traumatic brain injury.

  2019cites this paper
• Neonatal cerebral hypoxia-ischemia in mice triggers age-dependent vascular effects and disabilities in adults; implication of tissue plasminogen activator (tPA).

  2019cites this paper
• Oxygen-Glucose Deprivation/Reoxygenation-Induced Barrier Disruption at the Human Blood–Brain Barrier is Partially Mediated Through the HIF-1 Pathway

  2019cites this paper
• Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells

  2018cites this paper
• A review of the role of cav-1 in neuropathology and neural recovery after ischemic stroke

  2018cites this paper
• Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood–Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway

  2018cites this paper
• Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood–Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway

  2018cites this paper
• Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

  2018cites this paper
• Chronic N-acetylcysteine treatment alleviates acute lipopolysaccharide-induced working memory deficit through upregulating caveolin-1 and synaptophysin in mice

  2017cites this paper
• Melatonin Supplementation, a Strategy to Prevent Neurological Diseases through Maintaining Integrity of Blood Brain Barrier in Old People

  2017cites this paper
• β2-Adrenergic Receptor-Mediated HIF-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia

  2017cites this paper
• Corrigendum: β2-Adrenergic Receptor-Mediated HIF-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia

  2017cites this paper
• A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9.

  2017cites this paper
• Blood-brain barrier dysfunction and recovery after ischemic stroke.

  2017cites this paper
• Expression of matrix Metalloprotein-9 (MMP-9) in rat models brain tissue of experimental Intracerebral Hemorrhage (ICH)

  2017cites this paper
• KLF2 and caveolin-1 as early indicators of acute lung injury induced by paraquat.

  2016cites this paper
• Expression of matrix Metalloprotein-9 (MMP-9) in rat models brain tissue of experimental Intracerebral Hemorrhage (ICH)

  2016cites this paper
• Expression of matrix Metalloprotein-9 (MMP-9) in rat models brain tissue of experimental Intracerebral Hemorrhage (ICH)

  2016cites this paper
• Regulation of Caveolin-1 Expression Determines Early Brain Edema After Experimental Focal Cerebral Ischemia

  2016cites this paper
• Study on the effect of urinary kallidinogenase after thrombolytic treatment for acute cerebral infarction.

  2015cites this paper
• Activation of matrix metalloproteinase in dorsal hippocampus drives improvement in spatial working memory after intra‐VTA nicotine infusion in rats

  2015cites this paper